R. Pusztai et al., RELATIONSHIP BETWEEN TUMOR (T) ANTIGEN EXPRESSION AND SUBSTITUENT EFFECTS ON BENZO[A]PHENOTHIAZINES, Anticancer research, 16(5A), 1996, pp. 2961-2964
Human adenovirus, oncogene-type 12 infected HEp-2 cells were exposed t
o six benzo[a]phenothiazines. 5-Oxo-5H-benzo[a]phenothiazine (4) and 6
-hydroxy-5-oxo-5H-benzo[a]phenothiazine (5) were moderately toxic. 9-M
ethyl-12H-benzo[a]phenothiazine (2), 10-methyl-12H-benzo[a]phenothiazi
ne (3), 6-methyl-5-oxo-5H-benzo[a]phenothiazine (6), and 12H-benzo[a]p
henothiazine (1) were not toxic in the system tested. 6-Methyl-5-oxo-5
H-benzo[a]phenothiazine (6) enhanced the expression of viral oncogene
product (tumor antigen) in the adenovirus infected cells. 5-Oxo-5H-ben
zo[a]phenothiazine (4) and 6-hydroxy-5-oxo-5H-benzo[a]phenothiazine (5
) reduced this effect. 6-Methyl-5-oxo-5H-benzo[a]phenothiazine (6), wi
th hyperconjugation due to the methyl group, increased the T antigen a
ctivity at higher dose concentrations, whereas 6-hydroxy-5-oxo-5H-benz
o[a]phenothiazine (5) with a hydroxy substituent had the opposite effe
ct on T antigen expression. The methyl substitution at positions C9 or
C10 increased the T antigen expression of adenovirus infected cells.